Kaye Foster-Cheek, Director at Agios Pharma, holds 12.48K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Prime Medicine, Inc. (Ticker: PRME), holds 5.80K shares in Johnson & Johnson (Ticker: JNJ).
Kaye Foster-Cheek latest transaction was an Uninformative Buy of $96.19K.
What was Kaye Foster-Cheek's most profitable transaction?
Kaye Foster-Cheek’s most profitable transaction was an Informative Sell of AGIO stock on March 7, 2024. The return on the trade was -3.20%.
What is Kaye Foster-Cheek's role in Agios Pharma?
Kaye Foster-Cheek's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.